Vision

To develop the most effective and affordable life-saving medicines for low-income countries, enabling access to advanced treatments for human diseases.

Mission

To discover and deliver life-saving technologies that improve and extend patients’ lives through continuous innovation and scientific excellence.

Focus Area: NanoCAR Therapeutics

Lysine Biotech is pioneering a new approach to NanoCAR Therapeutics—focused on affordability, safety, and effectiveness—to make advanced cancer treatments accessible to all and reduce the overall cost of care.

Learn More About Products R&D Pipline

Our Features

1.Long non coding reading frames endless RNA (lncrfeRNA)

Title: “Role of thymine in protein coding frames of mRNA sequences” published in the journal" Bioinformation. 2008. 2, 304-307. doi: 10.6026/97320630002304

— This approach represents a new generation of nanotherapeutics, where immune cells are genetically programmed to express NanoCARs—synthetic receptors that direct them to identify and eliminate diseased cells—effectively creating ‘programmable medicines.

Learn More About Research and Development